The Journal of Clinical Psychiatry

Page 238

More JCP Articles

Original Research

The Utility of Attention-Deficit/Hyperactivity Disorder Screening Instruments in Individuals Seeking Treatment for Substance Use Disorders

November 15, 2012

Frances Rudnick Levin, Elias Dakwar, Andrew Glass, et al

Educational Activity

Beyond the Resistance: How Novel Neurobiological Understandings of Depression May Lead to Advanced Treatment Strategies

November 15, 2012

Rakesh Jain, W. Clay Jackson

Article

Predictors of Suicide Attempt in Early-Onset, First-Episode Psychoses: A Longitudinal 24-Month Follow-Up Study

November 13, 2012

Celso Arango, Ana Gonzalez-Pinto, Inmaculada Baeza, et al

Article

Association Between White Matter Hyperintensity Severity and Cognitive Impairment According to the Presence of the Apolipoprotein E (APOE) ε4 Allele in the Elderly: Retrospective Analysis of Data From the CREDOS Study

October 30, 2012

Sang Joon Son, Kang Soo Lee, Yunhwan Lee, et al

Meta-Analysis

Can Psychotherapists Function as Their Own Controls? Meta-Analysis of the Crossed Therapist Design in Comparative Psychotherapy Trials

October 30, 2012

John C. Markowitz, Fredrik Falkenström, Hanske Jonker, et al

Original Research

Gabapentin Lawsuit Among Patients with Bipolar

October 16, 2012

Read our full evaluation on the $430 million gabapentin off-label marketing lawsuit and how it affected patients diagnosed with bipolar disorder.

Stephen B. Soumerai, Meredith J. Chace, Fang Zhang, et al

Original Research

Oral Scopolamine Augmentation in Moderate to Severe Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Study

October 16, 2012

Danial Khajavi, Mehdi Farokhnia, Amirhossein Modabbernia, et al

Article

Sensitivity and Specificity of the Mood Disorder Questionnaire as a Screening Tool for Bipolar Disorder During Pregnancy and the Postpartum Period

October 16, 2012

Meir Steiner, Benicio N. Frey, William Simpson, et al

Original Research

The Vasopressin V1b Receptor Antagonist SSR149415 in the Treatment of Major Depressive and Generalized Anxiety Disorders: Results From 4 Randomized, Double-Blind, Placebo-Controlled Studies

October 16, 2012

Stephen M. Stahl, Guy Griebel, Sandra Beeské

Review Article

Beyond White Blood Cell Monitoring: Screening in the Initial Phase of Clozapine Therapy

October 15, 2012

Dan Cohen, Jan P. A. M. Bogers, Daniel van Dijk, et al

Book Review

Child Psychology and Psychiatry: Frameworks for Practice, 2nd ed

October 15, 2012

Edwin J. Mikkelsen

Commentary

Monitoring Clozapine Adverse Effects Calls for the Integration of Protocol and Good Clinical Practice

October 15, 2012

M. Bak

« 1 … 236 237 238 239 240 … 765 »

The Utility of Attention-Deficit/Hyperactivity Disorder Screening Instruments in Individuals Seeking Treatment for Substance Use Disorders

Beyond the Resistance: How Novel Neurobiological Understandings of Depression May Lead to Advanced Treatment Strategies

Predictors of Suicide Attempt in Early-Onset, First-Episode Psychoses: A Longitudinal 24-Month Follow-Up Study

Association Between White Matter Hyperintensity Severity and Cognitive Impairment According to the Presence of the Apolipoprotein E (APOE) ε4 Allele in the Elderly: Retrospective Analysis of Data From the CREDOS Study

Can Psychotherapists Function as Their Own Controls? Meta-Analysis of the Crossed Therapist Design in Comparative Psychotherapy Trials

Gabapentin Lawsuit Among Patients with Bipolar

Oral Scopolamine Augmentation in Moderate to Severe Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Study

Sensitivity and Specificity of the Mood Disorder Questionnaire as a Screening Tool for Bipolar Disorder During Pregnancy and the Postpartum Period

The Vasopressin V1b Receptor Antagonist SSR149415 in the Treatment of Major Depressive and Generalized Anxiety Disorders: Results From 4 Randomized, Double-Blind, Placebo-Controlled Studies

Beyond White Blood Cell Monitoring: Screening in the Initial Phase of Clozapine Therapy

Child Psychology and Psychiatry: Frameworks for Practice, 2nd ed

Monitoring Clozapine Adverse Effects Calls for the Integration of Protocol and Good Clinical Practice

ELSEWHERE:

FOLLOW US:

More JCP Articles

The Utility of Attention-Deficit/Hyperactivity Disorder Screening Instruments in Individuals Seeking Treatment for Substance Use Disorders

Beyond the Resistance: How Novel Neurobiological Understandings of Depression May Lead to Advanced Treatment Strategies

Predictors of Suicide Attempt in Early-Onset, First-Episode Psychoses: A Longitudinal 24-Month Follow-Up Study

Association Between White Matter Hyperintensity Severity and Cognitive Impairment According to the Presence of the Apolipoprotein E (APOE) ε4 Allele in the Elderly: Retrospective Analysis of Data From the CREDOS Study

Can Psychotherapists Function as Their Own Controls? Meta-Analysis of the Crossed Therapist Design in Comparative Psychotherapy Trials

Gabapentin Lawsuit Among Patients with Bipolar

Oral Scopolamine Augmentation in Moderate to Severe Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Study

Sensitivity and Specificity of the Mood Disorder Questionnaire as a Screening Tool for Bipolar Disorder During Pregnancy and the Postpartum Period

The Vasopressin V1b Receptor Antagonist SSR149415 in the Treatment of Major Depressive and Generalized Anxiety Disorders: Results From 4 Randomized, Double-Blind, Placebo-Controlled Studies

Beyond White Blood Cell Monitoring: Screening in the Initial Phase of Clozapine Therapy

Child Psychology and Psychiatry: Frameworks for Practice, 2nd ed

Monitoring Clozapine Adverse Effects Calls for the Integration of Protocol and Good Clinical Practice

Expert Consensus on Aripiprazole LAIs in Clinical Practice

Subscribe to readmore articles

Subscribe to read
more articles